These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16536337)

  • 1. An alarming complication of Candida albicans antigen treatment of recalcitrant warts.
    Signore RJ
    Dermatitis; 2005 Dec; 16(4):216; author reply 216-7. PubMed ID: 16536337
    [No Abstract]   [Full Text] [Related]  

  • 2. The painful purple digit: an alarming complication of Candida albicans antigen treatment of recalcitrant warts.
    Perman M; Sterling JB; Gaspari A
    Dermatitis; 2005 Mar; 16(1):38-40. PubMed ID: 15996350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida albicans intralesional injection immunotherapy of warts.
    Signore RJ
    Cutis; 2002 Sep; 70(3):185-92. PubMed ID: 12353895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Study of Intralesional Vitamin D3 Injection and Candida Albicans Antigen in Treating Plantar Warts.
    Abdelaal MA; Abdelaziz HM; Ahmed KA; Elsaie ML
    J Drugs Dermatol; 2021 May; 20(5):546-549. PubMed ID: 33938709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candida albicans Immunotherapy for Verrucae Plantaris.
    Vlahovic TC; Spadone S; Dunn SP; Fussell T; Hersh I; Green T; Merrill J; Ghosh P; Tran T
    J Am Podiatr Med Assoc; 2015 Sep; 105(5):395-400. PubMed ID: 26429607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intralesional immunotherapy for warts using a combination of skin test antigens: a safe and effective therapy.
    Johnson SM; Horn TD
    J Drugs Dermatol; 2004; 3(3):263-5. PubMed ID: 15176159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Goodbye warts, hello vitiligo: Candida antigen-induced depigmentation.
    Wilmer EN; Burkhart CN; Morrell DS
    Pediatr Dermatol; 2013; 30(6):e214-5. PubMed ID: 23252470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intralesional vitamin D3 versus Candida antigen immunotherapy in the treatment of multiple recalcitrant plantar warts: A comparative case-control study.
    Fathy G; Sharara MA; Khafagy AH
    Dermatol Ther; 2019 Sep; 32(5):e12997. PubMed ID: 31225688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intralesional immunotherapy of warts with mumps, Candida, and Trichophyton skin test antigens: a single-blinded, randomized, and controlled trial.
    Horn TD; Johnson SM; Helm RM; Roberson PK
    Arch Dermatol; 2005 May; 141(5):589-94. PubMed ID: 15897380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of recalcitrant verruca vulgaris with Candida antigen in patient with human immunodeficiency virus.
    Summers P; Richards-Altmon P; Halder R
    J Drugs Dermatol; 2009 Mar; 8(3):268-9. PubMed ID: 19271374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The status of immunotherapy in the United States, 2002.
    Silverberg NB
    Cutis; 2002 Sep; 70(3):155-6. PubMed ID: 12353888
    [No Abstract]   [Full Text] [Related]  

  • 12. Alternating intralesional purified protein derivative and Candida antigen versus either agent alone in the treatment of multiple common warts.
    Nofal A; Yehia E; Khater E; Bessar H
    J Am Acad Dermatol; 2020 Jul; 83(1):208-210. PubMed ID: 32006600
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined bivalent human papillomavirus vaccine and Candida antigen versus Candida antigen alone in the treatment of recalcitrant warts.
    Marei A; Nofal A; Alakad R; Abdel-Hady A
    J Cosmet Dermatol; 2020 Mar; 19(3):758-762. PubMed ID: 31328869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candida immunotherapy of warts.
    Signore RJ
    Arch Dermatol; 2001 Sep; 137(9):1250-1. PubMed ID: 11559230
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase 1 clinical trial of intralesional injection of Candida antigen for the treatment of warts.
    Kim KH; Horn TD; Pharis J; Kincannon J; Jones R; O'Bryan K; Myers J; Nakagawa M
    Arch Dermatol; 2010 Dec; 146(12):1431-3. PubMed ID: 21173332
    [No Abstract]   [Full Text] [Related]  

  • 16. Palmar and plantar pustulosis elicited by Candida antigen.
    Uehara M
    Arch Dermatol; 1978 May; 114(5):730-1. PubMed ID: 348116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of peripheral blood lymphocytes from rabbits to Candida albicans antigens.
    Zawisza-Zenkteler W; Zamiechowska-Miazga J
    Bull Acad Pol Sci Biol; 1974; 22(5):293-8. PubMed ID: 4607027
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Candida albicans: an immune response modifier.
    Signore RJ
    Pediatr Dermatol; 2004; 21(4):512. PubMed ID: 15283807
    [No Abstract]   [Full Text] [Related]  

  • 19. Significance of interferon gamma in the prediction of successful therapy of common warts by intralesional injection of Candida antigen.
    Nofal A; Marei A; Amer A; Amen H
    Int J Dermatol; 2017 Oct; 56(10):1003-1009. PubMed ID: 28791682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy of alopecia areata with intralesional Candida antigen.
    Rosenberg EW; Skinner RB
    Pediatr Dermatol; 2006; 23(3):299. PubMed ID: 16780487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.